No profile data available.
Abbott Laboratories (ABT) is a healthcare company in the various healthcare equipment manufacturing industry, based in Abbott Park, United States, with about 122,000 full-time employees.
It reported revenue of $44.33 billion for fiscal year 2025, up 5.7% from fiscal year 2024, and net income of $6.52 billion. Its largest business segment, Medical Devices, brought in 48% of segment revenue in fiscal year 2025; United States was the largest region with 39%. Its market capitalization was $173.48 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Abbott Laboratories reported $44.33 billion in revenue for fiscal year 2025, up 5.7% from $41.95 billion in fiscal year 2024.
Medical Devices, with $21.39 billion or 48% of segment revenue in fiscal year 2025. Next: Diagnostic Products (20%) and Nutritional Products (19%).
United States: 39% of revenue by region in fiscal year 2025, followed by All Other Countries (36%).
$173.48 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Medtronic plc (MDT), Stryker Corporation (SYK), Boston Scientific Corporation (BSX), Becton, Dickinson and Company (BDX).